You need to enable JavaScript to run this app.
Recon: FDA Panel Split on Sanofi-Lexicon Diabetes Drug; Lilly's Latruvo Fails Confirmatory Study
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher